Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders
- 24 February 2009
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 72 (8), 712-717
- https://doi.org/10.1212/01.wnl.0000343001.36493.ae
Abstract
Background: Posterior reversible encephalopathy syndrome (PRES) is characterized by vasogenic subcortical edema without infarction. It has been associated with hypertensive crises and with immunosuppressive medications but not with neuromyelitis optica (NMO). Methods: We reviewed the clinical and neuroimaging features of five NMO–immunoglobulin G (IgG) seropositive white women who experienced an episode of PRES and had a coexisting NMO spectrum disorder (NMOSD). We also tested for the aquaporin-4 (AQP4) water channel autoantibody (NMO-IgG) in 14 patients from an independently ascertained cohort of individuals with PRES. Results: All five patients developed abrupt confusion and depressed consciousness consistent with PRES. The encephalopathy resolved completely within 7 days. Comorbid conditions or interventions recognized to be associated with PRES included orthostatic hypotension with supine hypertension, plasma exchange, IV immunoglobulin treatment, and high-dose IV methylprednisolone. Brain MRI studies revealed bilateral T2-weighted (T2W) hyperintense signal abnormalities, primarily in frontal, parieto-occipital, and cerebellar regions. Three patients had highly symmetric lesions and three had gadolinium-enhancing lesions. Follow-up neuroimaging revealed partial or complete disappearance of T2W hyperintensity or gadolinium-enhancing lesions in all five patients. Patients with PRES without NMOSD were uniformly NMO-IgG seronegative. Conclusions: Brain lesions in some patients with neuromyelitis optica spectrum disorder (NMOSD) may be accompanied by vasogenic edema and manifest as posterior reversible encephalopathy syndrome (PRES). Water flux impairment due to aquaporin-4 autoimmunity may predispose to PRES in patients with NMOSD who experience blood pressure fluctuations or who are treated with therapies that can cause rapid fluid shifts. ADC = apparent diffusion coefficient; AQP4 = aquaporin-4; DWI = diffusion-weighted imaging; FLAIR = fluid-attenuated inversion recovery; Gd = gadolinium; IgG = immunoglobulin G; IVIg = IV immunoglobulin; IVMP = IV methylprednisolone; LETM = longitudinally extensive transverse myelitis; NMO = neuromyelitis optica; NMOSD = neuromyelitis optica spectrum disorder; ON = optic neuritis; PLEX = plasma exchange; PRES = posterior reversible encephalopathy syndrome; T2W = T2-weighted.Keywords
This publication has 28 references indexed in Scilit:
- CNS aquaporin-4 autoimmunity in childrenNeurology, 2008
- RELAPSING INFLAMMATORY OPTICNEURITIS: IS IT NEUROMYELITIS OPTICA?Neurology, 2008
- Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological studyMultiple Sclerosis Journal, 2008
- Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy SyndromeAmerican Journal of Neuroradiology, 2007
- Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosisBrain, 2007
- Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitisAnnals of Neurology, 2006
- Aquaporin‐4 facilitates reabsorption of excess fluid in vasogenic brain edemaThe FASEB Journal, 2004
- The molecular basis of water transport in the brainNature Reviews Neuroscience, 2003
- Immunosuppression‐induced leukoencephalopathy from tacrolimus (FK506)Annals of Neurology, 1996
- MR Demonstration of Reversible Brain Abnormalities in EclampsiaJournal of Computer Assisted Tomography, 1989